Carisma Therapeutics Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Carisma Therapeutics Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and growth rate from Q1 2019 to Q2 2024.
  • Carisma Therapeutics Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending June 30, 2024 was $226K, a 3.2% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $226K +$7K +3.2% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $427K +$208K +95% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $219K Dec 31, 2023 10-K 2024-04-01
Q3 2023 $219K Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $219K Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $219K Mar 31, 2023 10-Q 2023-05-11
Q4 2020 $122K Dec 31, 2020 10-K 2021-03-15
Q3 2019 $113K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $113K Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $116K Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.